XPO7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.023200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.369800E-01
Normal-vs-Stage2
4.026800E-01
Normal-vs-Stage3
1.092790E-01
Normal-vs-Stage4
7.972600E-01
Stage1-vs-Stage2
9.242800E-01
Stage1-vs-Stage3
2.800000E-01
Stage1-vs-Stage4
3.517400E-01
Stage2-vs-Stage3
2.358000E-01
Stage2-vs-Stage4
1.702990E-01
Stage3-vs-Stage4
1.431990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.851400E-01
Normal-vs-AfricanAmerican
8.755200E-01
Normal-vs-Asian
2.037000E-01
Caucasian-vs-AfricanAmerican
3.621000E-01
Caucasian-vs-Asian
4.957200E-01
AfricanAmerican-vs-Asian
2.601200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.405800E-01
Normal-vs-Female
4.932200E-01
Male-vs-Female
2.890800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.323900E-02
Normal-vs-Age(41-60Yrs)
6.862000E-01
Normal-vs-Age(61-80Yrs)
3.516600E-01
Normal-vs-Age(81-100Yrs)
1.263360E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.790400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.239400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.002000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.745800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.154000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.677400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.956400E-02
Normal-vs-Daily Drinker
1.410960E-01
Normal-vs-Weekly Drinker
4.593800E-01
Normal-vs-Occasional Drinker
6.420400E-01
Normal-vs-Social Drinker
9.779600E-01
Non Drinker-vs-Daily Drinker
8.986200E-01
Non Drinker-vs-Weekly Drinker
1.965820E-01
Non Drinker-vs-Occasional Drinker
3.043600E-02
Non Drinker-vs-Social Drinker
7.523700E-03
Daily Drinker-vs-Weekly Drinker
2.252800E-01
Daily Drinker-vs-Occasional Drinker
4.752200E-02
Daily Drinker-vs-Social Drinker
1.598500E-02
Weekly Drinker-vs-Occasional Drinker
5.614000E-01
Weekly Drinker-vs-Social Drinker
2.637400E-01
Occasional Drinker-vs-Social Drinker
4.910200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.635770E-01
Normal-vs-Grade 2
2.398400E-02
Normal-vs-Grade 3
3.001700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.303820E-01
Grade 1-vs-Grade 3
6.273600E-02
Grade 1-vs-Grade 4
1.635770E-01
Grade 2-vs-Grade 3
3.505400E-01
Grade 2-vs-Grade 4
2.398400E-02
Grade 3-vs-Grade 4
3.001700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.352000E-01
Normal-vs-NonDiabetic
3.616400E-01
Diabetic-vs-NonDiabetic
2.426400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.788200E-01
Normal-vs-NoPancreatitis
3.240200E-01
Pancreatitis-vs-NoPancreatitis
5.770200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.178200E-01
Normal-vs-N1
3.767200E-01
N0-vs-N1
7.596600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.307400E-01
Normal-vs-TP53-NonMutant
6.217400E-01
TP53-Mutant-vs-TP53-NonMutant
5.439400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
